Categories: News

Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 21, 2026 /PRNewswire/ — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2025 financial results before the U.S. markets open on Wednesday, February 11, 2026.

- Advertisement -

Later that same morning, Cellebrite will host a live conference call and webcast to review the Company’s financial results for the fourth quarter of 2025 and discuss its 2026 outlook. Relevant details include:

- Advertisement -

Date:

Wednesday, February 11, 2026

Time:

8:30 a.m. ET

Call-In Number:

203-518-9814 / 800-274-8461

Conference ID:  

CLBTQ425

Event URL:

https://investors.cellebrite.com/events/event-details/cellebrite-q4-2025-financial-results-conference-call-webcast

Live Webcast URL:

https://edge.media-server.com/mmc/p/v9sjjqnr

In conjunction with the conference call and webcast, historical financial tables and supplemental data will be available on the quarterly results section of Company’s investor relations website at https://investors.cellebrite.com/financial-information/quarterly-results.

- Advertisement -

About Cellebrite
Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate more than 1.5 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com, https://investors.cellebrite.com/investors and find us on social media @Cellebrite.

- Advertisement -

Investor Relations
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760

- Advertisement -

Media
Victor Cooper
Sr. Director of Corporate Communications
Victor.cooper@cellebrite.com
+1 404.804.5910

- Advertisement -

Logo – https://mma.prnewswire.com/media/2855183/Cellebrite_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cellebrite-to-report-fourth-quarter-and-fiscal-year-2025-financial-results-on-february-11-2026-302665739.html

- Advertisement -

Recent Posts

New7Wonders Honours the Official 7 Wonders Day this year in Viet Nam

ZURICH, July 7, 2026 /PRNewswire/ -- New7Wonders is proud to announce that 7 Wonders Day is being…

3 hours ago

SAUDI INTRODUCES “PACKAGE VISA”, INTEGRATING TRAVEL BOOKING WITH EASIER VISA APPLICATION

A fully digital initiative connecting visa application directly to travel bookings, making it easier to…

3 hours ago

Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma

EAST RUTHERFORD, N.J., July 7, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing…

4 hours ago

Prayogtvisha Launches STEM Education Programme Pilot at SSV International School, Guntur

BENGALURU, India, July 7, 2026 /PRNewswire/ -- Prayogtvisha, an education company founded by Menterra Social…

4 hours ago

Giftex unveils The Collectors’ Cove: India’s only collector-first destination celebrating remarkable works, objects and exceptional craftsmanship

~An invitation-only cultural platform bringing together outstanding works, collectible objects and the world's finest brands…

4 hours ago

Healome Therapeutics Closes 2 Million Seed Round Led by Empirical Ventures to Advance Eye-Drop Matrix Technology for Ocular Surface Diseases

BIRMINGHAM, England, July 7, 2026 /PRNewswire/ -- Healome Therapeutics ("Healome"), a University of Birmingham spinout…

5 hours ago